apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Azalpho Injection
  3. Azalpho Injection Substitute

Azalpho Injection Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

AZACITIDINE-100MG

Uses:

Azalpho Injection is used in the treatment of Myelodysplastic syndrome, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. The detailed uses of Azalpho Injection are as follows:<br/>• Myelodysplastic Syndromes (MDS): Azalpho Injection helps improve blood counts and reduce the need for transfusions.<br/>• Acute Myeloid Leukemia (AML): Azalpho Injection is used especially in patients who are in remission but cannot undergo intensive chemotherapy.<br/>• Chronic Myelomonocytic Leukemia (CMML): Azalpho Injection is used to treat MDS and myeloproliferative disorders.<br/>

Medicinal Benefits:

Azalpho Injection belongs to the group of medicines called anti-metabolites used to treat myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. Azalpho Injection contains Azacitidine, a nucleoside metabolic inhibitor which works by preventing cancer cells from growing. It incorporates into the genetic material of the cells and interferes with the production of new DNA and RNA. This helps correct problems with the maturation and growth of young blood cells in the bone marrow, which causes myelodysplastic disorders.

FAQs

Azalpho Injection is used to treat Myelodysplastic syndrome, chronic myelomonocytic leukaemia, and acute myeloid leukaemia.

Azalpho Injection works by preventing cancer cells from growing. Thereby, it helps treat cancer.

Men should avoid fathering a child whilst on treatment with Azalpho Injection. Consult the doctor if you wish to conserve your sperm before starting the treatment. Use effective contraception during the treatment with Azalpho Injection and for three months after stopping the treatment.

Azalpho Injection may cause a serious immune reaction known as differentiation syndrome. Consult the doctor immediately if you experience fever, rash, difficulty breathing, cough, decreased urine, rapid weight gain, low blood pressure, or swelling of the legs or arms.

No, Azalpho Injection is not a vesicant. It is a cytotoxic chemotherapy drug used to treat certain types of blood cancer, such as myelodysplastic syndrome (MDS). It is not known to cause severe tissue damage if it leaks from the injection site.

No, Azalpho Injection does not cause hair loss.

Yes, Azalpho Injection is a type of chemotherapy. It is used to treat certain types of blood cancers, such as myelodysplastic syndrome (MDS) and some forms of leukaemia.

Yes, Azalpho Injection is a cytotoxic drug. It works by interfering with the growth of cancer cells, which helps to slow down or stop their multiplication.

The common side effects of Azalpho Injection are nausea, vomiting, diarrhoea, constipation, weakness, headache, and injection site reactions. If any of these side effects persist or worsen, please consult your doctor.